Clinical Trial: Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Clinical Study on the Treatment of Hypertensive Cerebral Hemorrhage With Panax Notoginseng Saponins

Brief Summary: The purpose of this study is to determine whether panax notoginseng saponins are effective in the treatment of Hypertensive Intracerebral Hemorrhage Patients.

Detailed Summary: Patients with HICH were randomly assigned to receive either PNS integrated with conventional therapy. Patients were treated with conventional therapy for 3 days, then plus PNS for 14 days. Patients in the control group received conventional therapy for 17days. Hematoma volume measured by CT scanning, National Institutes of Health Stroke Scale (NIHSS) scores, Barthel index (BI), all the three were used to evaluate the therapeutic effect for both groups after two weeks of intervention.
Sponsor: The First People's Hospital of Jingzhou

Current Primary Outcome:

  • Hematoma volume [ Time Frame: within the 14 days after two weeks of intervention ]
  • National Institutes of Health Stroke Scale (NIHSS) scores [ Time Frame: within the 14 days after two weeks of intervention ]
    were measured for stroke severity
  • Barthel index [ Time Frame: within the 14 days after two weeks of intervention ]
    were measured for quality of life


Original Primary Outcome: Same as current

Current Secondary Outcome: adverse events [ Time Frame: 14 days ]

such as rash, allergic shock


Original Secondary Outcome: Same as current

Information By: The First People's Hospital of Jingzhou

Dates:
Date Received: December 13, 2016
Date Started: May 2014
Date Completion:
Last Updated: December 16, 2016
Last Verified: December 2016